Arvinas

February 11, 2021

Astra places its bet in oestrogen receptor degradation

Asco 2020 movers – cell therapy companies dominate the risers

Adaptimmune and Allogene led numerous cell therapy companies higher over the Asco period, while Cytomx and Arvinas suffered the biggest losses.

May 14, 2020

Asco 2020 – abstract dump triggers first moves

An early look at data from the huge cancer conference boosts Allogene and Immunogen, while Arvinas and Cytomx suffer.

March 31, 2016

Interview – C4 starts life with a bang